Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

586
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
586
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

559
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
559
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

454
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
454
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validating the European LeukemiaNet 2022 Guidelines in a Middle Eastern Acute Myeloid Leukemia Cohort: Correlation With Survival Outcomes and Comparison to ELN 2017.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2024
Same author

KIR genotype and haplotype repertoire in Kuwaiti healthy donors, hematopoietic cell transplant recipients and healthy family members.

HLA·2023
Same author

Identification of a novel HLA-DRB4 allele, HLA-DRB4*01:152 in a Kuwaiti family.

HLA·2022
Same author

Identification of the novel HLA-DPA1 allele, HLA-DPA1*01:03:34 in a Kuwaiti family.

HLA·2022
Same author

Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms.

Clinical lymphoma, myeloma & leukemia·2021

Related Experiment Video

Updated: Feb 27, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K

Kuwait bone marrow transplantation activities.

Salem H Al Shemmari1, Reem Ameen2

  • 1Department of Medicine, Health Sciences Center, Kuwait University, Jabriya, Kuwait.

Hematology/Oncology and Stem Cell Therapy
|July 1, 2017
PubMed
Summary

Kuwait established stem cell transplantation in 2000, expanding to allogeneic transplants in 2011. Donor availability and drug shortages currently hinder program growth.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.3K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

14.1K

Related Experiment Videos

Last Updated: Feb 27, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.3K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

14.1K

Area of Science:

  • Hematology
  • Transplantation Medicine

Background:

  • Kuwait initiated its stem cell transplantation program in 2000, initially focusing on autologous peripheral blood stem cell transplants.
  • The allogeneic stem cell transplantation program commenced in 2011, targeting acute leukemia and hemoglobinopathies.

Purpose of the Study:

  • To provide an overview of the development and current status of stem cell transplantation in Kuwait.
  • To identify key milestones and challenges in establishing and expanding the national bone marrow transplantation program.

Main Methods:

  • Retrospective analysis of program initiation and development.
  • Establishment of the Kuwait National Bone Marrow Registry in 2012.
  • Identification of obstacles to program expansion.

Main Results:

  • Successful implementation of both autologous and allogeneic stem cell transplantation programs.
  • Establishment of the Kuwait National Bone Marrow Registry.
  • Key challenges identified: donor availability and medication shortages.

Conclusions:

  • The Kuwaiti stem cell transplantation program has seen significant development since 2000, requiring substantial teamwork and health planner support.
  • Expansion of the bone marrow transplantation program is currently limited by donor availability and drug shortages.